May 9, 2018 / 9:16 PM / 11 days ago

BRIEF-HLS Therapeutics Announces Normal Course Issuer Bid

May 9 (Reuters) - HLS Therapeutics Inc:

* HLS THERAPEUTICS ANNOUNCES NORMAL COURSE ISSUER BID

* HLS THERAPEUTICS - PURSUANT TO NORMAL COURSE ISSUER BID, CO MAY PURCHASE FOR CANCELLATION UP TO AGGREGATE OF 1.4 MILLION OF ITS ISSUED & OUTSTANDING SHARES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below